-
SBIO Dashboard
- Holdings
ALPS Medical Breakthroughs ETF
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
CORT Corcept Therapeutics Incorporated | 4.79 mm | 82.98 k shares | 3.88 | Common equity | Long | USA |
KRYS Krystal Biotech, Inc. | 4.60 mm | 23.29 k shares | 3.73 | Common equity | Long | USA |
RNA Avidity Biosciences, Inc. | 3.94 mm | 91.68 k shares | 3.20 | Common equity | Long | USA |
Alkermes Plc | 3.81 mm | 131.39 k shares | 3.10 | Common equity | Long | Ireland |
ACLX Arcellx, Inc. | 3.76 mm | 42.67 k shares | 3.05 | Common equity | Long | USA |
CRNX Crinetics Pharmaceuticals, Inc. | 3.62 mm | 63.23 k shares | 2.94 | Common equity | Long | USA |
IMVT Immunovant, Inc. | 3.31 mm | 117.52 k shares | 2.69 | Common equity | Long | USA |
DNLI Denali Therapeutics Inc. | 2.77 mm | 110.60 k shares | 2.24 | Common equity | Long | USA |
AGIO Agios Pharmaceuticals, Inc. | 2.66 mm | 44.77 k shares | 2.16 | Common equity | Long | USA |
PTCT PTC Therapeutics, Inc. | 2.66 mm | 60.55 k shares | 2.16 | Common equity | Long | USA |
VRNA Verona Pharma plc | 2.58 mm | 65.14 k shares | 2.10 | Common equity | Long | UK |
XENE Xenon Pharmaceuticals Inc. | 2.53 mm | 59.32 k shares | 2.05 | Common equity | Long | Canada |
MRUS Merus N.V. | 2.50 mm | 55.67 k shares | 2.03 | Common equity | Long | Netherlands |
MLTX MoonLake Immunotherapeutics | 2.48 mm | 45.62 k shares | 2.02 | Common equity | Long | Cayman Islands |
EWTX Edgewise Therapeutics, Inc. | 2.37 mm | 71.73 k shares | 1.92 | Common equity | Long | USA |
FOLD Amicus Therapeutics, Inc. | 2.36 mm | 236.36 k shares | 1.91 | Common equity | Long | USA |
VERA Vera Therapeutics, Inc. | 2.29 mm | 46.08 k shares | 1.86 | Common equity | Long | USA |
VCEL Vericel Corporation | 2.24 mm | 38.61 k shares | 1.82 | Common equity | Long | USA |
Zai Lab, Ltd.
|
2.24 mm | 77.72 k shares | 1.82 | Common equity | Long | Cayman Islands |
ACAD ACADIA Pharmaceuticals Inc. | 2.16 mm | 132.30 k shares | 1.75 | Common equity | Long | USA |
PTGX Protagonist Therapeutics, Inc. | 2.02 mm | 46.10 k shares | 1.64 | Common equity | Long | USA |
GERN Geron Corporation | 1.95 mm | 474.32 k shares | 1.59 | Common equity | Long | USA |
CGON CG Oncology, Inc. Common stock | 1.95 mm | 56.06 k shares | 1.58 | Common equity | Long | USA |
IDYA IDEAYA Biosciences, Inc. | 1.85 mm | 67.55 k shares | 1.50 | Common equity | Long | USA |
MIRM Mirum Pharmaceuticals, Inc. | 1.79 mm | 38.77 k shares | 1.45 | Common equity | Long | USA |
AKRO Akero Therapeutics, Inc. | 1.77 mm | 55.21 k shares | 1.44 | Common equity | Long | USA |
KROS Keros Therapeutics, Inc. | 1.68 mm | 29.05 k shares | 1.36 | Common equity | Long | USA |
APGE Apogee Therapeutics, Inc. | 1.67 mm | 36.94 k shares | 1.35 | Common equity | Long | USA |
LBPH Longboard Pharmaceuticals, Inc. | 1.66 mm | 27.62 k shares | 1.34 | Common equity | Long | USA |
SLNO Soleno Therapeutics, Inc. | 1.60 mm | 30.36 k shares | 1.30 | Common equity | Long | USA |
TARS Tarsus Pharmaceuticals, Inc. | 1.60 mm | 30.44 k shares | 1.30 | Common equity | Long | USA |
IRON Disc Medicine, Inc. | 1.51 mm | 23.83 k shares | 1.23 | Common equity | Long | USA |
ARVN Arvinas, Inc. | 1.49 mm | 55.61 k shares | 1.21 | Common equity | Long | USA |
MNKD MannKind Corporation | 1.47 mm | 216.87 k shares | 1.19 | Common equity | Long | USA |
CLDX Celldex Therapeutics, Inc. | 1.45 mm | 52.73 k shares | 1.17 | Common equity | Long | USA |
NAMS NewAmsterdam Pharma Company N.V. | 1.44 mm | 72.52 k shares | 1.17 | Common equity | Long | Netherlands |
GLPG Galapagos NV | 1.44 mm | 51.94 k shares | 1.17 | Common equity | Long | Belgium |
IMCR Immunocore Holdings plc | 1.31 mm | 39.92 k shares | 1.06 | Common equity | Long | UK |
XNCR Xencor, Inc. | 1.28 mm | 50.05 k shares | 1.04 | Common equity | Long | USA |
NTLA Intellia Therapeutics, Inc. | 1.24 mm | 79.33 k shares | 1.01 | Common equity | Long | USA |
BCRX BioCryst Pharmaceuticals, Inc. | 1.23 mm | 164.59 k shares | 1.00 | Common equity | Long | USA |
NMRA Neumora Therapeutics, Inc. Common Stock | 1.22 mm | 123.01 k shares | 0.99 | Common equity | Long | USA |
SNDX Syndax Pharmaceuticals, Inc. | 1.16 mm | 69.12 k shares | 0.94 | Common equity | Long | USA |
PRAX Praxis Precision Medicines, Inc. | 1.12 mm | 13.98 k shares | 0.91 | Common equity | Long | USA |
RCUS Arcus Biosciences, Inc. | 1.10 mm | 71.16 k shares | 0.89 | Common equity | Long | USA |
SPRY ARS Pharmaceuticals, Inc. | 1.07 mm | 73.47 k shares | 0.87 | Common equity | Long | USA |
VRDN Viridian Therapeutics, Inc. | 1.05 mm | 48.75 k shares | 0.85 | Common equity | Long | USA |
DAWN Day One Biopharmaceuticals, Inc. | 1.01 mm | 72.15 k shares | 0.82 | Common equity | Long | USA |
AUPH Aurinia Pharmaceuticals Inc. | 1.00 mm | 113.19 k shares | 0.81 | Common equity | Long | Canada |
PHVS Pharvaris N.V. | 964.54 k | 44.04 k shares | 0.78 | Common equity | Long | Netherlands |
COGT Cogent Biosciences, Inc. | 865.87 k | 91.05 k shares | 0.70 | Common equity | Long | USA |
ArriVent Biopharma, Inc.
|
855.60 k | 28.56 k shares | 0.69 | Common equity | Long | USA |
REPL Replimune Group, Inc. | 766.59 k | 54.45 k shares | 0.62 | Common equity | Long | USA |
ETNB 89bio, Inc. | 761.31 k | 84.68 k shares | 0.62 | Common equity | Long | USA |
Liquidia Corporation | 739.15 k | 64.00 k shares | 0.60 | Common equity | Long | USA |
PRTA Prothena Corporation plc | 702.41 k | 43.33 k shares | 0.57 | Common equity | Long | Ireland |
PLRX Pliant Therapeutics, Inc. | 692.93 k | 50.21 k shares | 0.56 | Common equity | Long | USA |
KURA Kura Oncology, Inc. | 674.54 k | 61.10 k shares | 0.55 | Common equity | Long | USA |
CRGX CARGO Therapeutics, Inc. Common Stock | 665.13 k | 36.59 k shares | 0.54 | Common equity | Long | USA |
ERAS Erasca, Inc. | 646.57 k | 226.08 k shares | 0.52 | Common equity | Long | USA |
AVXL Anavex Life Sciences Corp. | 630.02 k | 66.60 k shares | 0.51 | Common equity | Long | USA |
ANAB AnaptysBio, Inc. | 558.90 k | 22.39 k shares | 0.45 | Common equity | Long | USA |
DNTH Dianthus Therapeutics, Inc. | 556.86 k | 23.21 k shares | 0.45 | Common equity | Long | USA |
TRML Tourmaline Bio, Inc. | 535.98 k | 20.58 k shares | 0.44 | Common equity | Long | USA |
MLYS Mineralys Therapeutics, Inc. | 508.68 k | 39.83 k shares | 0.41 | Common equity | Long | USA |
FULC Fulcrum Therapeutics, Inc. | 492.98 k | 128.05 k shares | 0.40 | Common equity | Long | USA |
ALT Altimmune, Inc. | 490.62 k | 57.25 k shares | 0.40 | Common equity | Long | USA |
OLMA Olema Pharmaceuticals, Inc. | 481.34 k | 47.56 k shares | 0.39 | Common equity | Long | USA |
ALLO Allogene Therapeutics, Inc. | 452.52 k | 182.47 k shares | 0.37 | Common equity | Long | USA |
URGN UroGen Pharma Ltd. | 451.47 k | 35.55 k shares | 0.37 | Common equity | Long | Israel |
SVRA Savara Inc. | 449.45 k | 133.76 k shares | 0.36 | Common equity | Long | USA |
FLGT Fulgent Genetics, Inc. | 437.04 k | 23.88 k shares | 0.35 | Common equity | Long | USA |
IRWD Ironwood Pharmaceuticals, Inc. | 430.67 k | 122.35 k shares | 0.35 | Common equity | Long | USA |
YMAB Y-mAbs Therapeutics, Inc. | 424.75 k | 35.63 k shares | 0.34 | Common equity | Long | USA |
ANNX Annexon, Inc. | 417.12 k | 77.39 k shares | 0.34 | Common equity | Long | USA |
Arcturus Therapeutics Holdings, Inc. | 416.92 k | 22.73 k shares | 0.34 | Common equity | Long | USA |
CELC Celcuity Inc. | 401.00 k | 31.33 k shares | 0.33 | Common equity | Long | USA |
SLRN Acelyrin, Inc. | 365.87 k | 80.41 k shares | 0.30 | Common equity | Long | USA |
TBPH Theravance Biopharma, Inc. | 360.48 k | 38.97 k shares | 0.29 | Common equity | Long | Cayman Islands |
GHRS GH Research PLC | 356.59 k | 39.93 k shares | 0.29 | Common equity | Long | Ireland |
AURA Aura Biosciences, Inc. | 341.27 k | 36.66 k shares | 0.28 | Common equity | Long | USA |
FDMT 4D Molecular Therapeutics, Inc. | 321.07 k | 40.95 k shares | 0.26 | Common equity | Long | USA |
ACIU AC Immune SA | 271.22 k | 79.77 k shares | 0.22 | Common equity | Long | Switzerland |
CMPS COMPASS Pathways plc | 250.67 k | 54.55 k shares | 0.20 | Common equity | Long | UK |
VNDA Vanda Pharmaceuticals Inc. | 236.08 k | 45.84 k shares | 0.19 | Common equity | Long | USA |
ITOS iTeos Therapeutics, Inc. | 235.64 k | 27.56 k shares | 0.19 | Common equity | Long | USA |
ALDX Aldeyra Therapeutics, Inc. | 232.26 k | 47.40 k shares | 0.19 | Common equity | Long | USA |
AVIR Atea Pharmaceuticals, Inc. | 230.31 k | 67.34 k shares | 0.19 | Common equity | Long | USA |
ZNTL Zentalis Pharmaceuticals, Inc. | 211.26 k | 58.52 k shares | 0.17 | Common equity | Long | USA |
ALEC Alector, Inc. | 208.23 k | 80.40 k shares | 0.17 | Common equity | Long | USA |
PROK ProKidney Corp. | 202.77 k | 101.39 k shares | 0.16 | Common equity | Long | Cayman Islands |
KYTX Kyverna Therapeutics, Inc. | 198.55 k | 34.41 k shares | 0.16 | Common equity | Long | USA |
KALV KalVista Pharmaceuticals, Inc. | 198.53 k | 97.80 k shares | 0.16 | Common equity | Long | USA |
STRO Sutro Biopharma, Inc. | 179.47 k | 67.73 k shares | 0.15 | Common equity | Long | USA |
Inhibrx Biosciences, Inc. | 173.99 k | 11.40 k shares | 0.14 | Common equity | Long | USA |
ENTA Enanta Pharmaceuticals, Inc. | 143.56 k | 16.69 k shares | 0.12 | Common equity | Long | USA |
INZY Inozyme Pharma, Inc. | 125.71 k | 46.39 k shares | 0.10 | Common equity | Long | USA |
ANRO Alto Neuroscience, Inc. | 97.83 k | 22.18 k shares | 0.08 | Common equity | Long | USA |
HLVX HilleVax, Inc. | 75.75 k | 39.25 k shares | 0.06 | Common equity | Long | USA |
State Street Institutional Treasury Plus Money Market Fund | 27.25 k | 27.25 k shares | 0.02 | Short-term investment vehicle | Long | USA |
AstraZeneca PLC | 0.04 | 36.59 k contracts | 0.00 | Equity derivative | N/A | USA |
Azn Ln - Cvr | 0.04 | 29.05 k contracts | 0.00 | Equity derivative | N/A | UK |
Radius Health CVR | 0.03 | 28.64 k contracts | 0.00 | Equity derivative | N/A | USA |
Chinook Therapeutics, Inc. | 0.02 | 20.70 k contracts | 0.00 | Equity derivative | N/A | USA |
OABI OmniAb, Inc. | 0 | 3.65 k contracts | 0.00 | Equity derivative | N/A | USA |
OABI OmniAb, Inc. | 0 | 3.65 k contracts | 0.00 | Equity derivative | N/A | USA |
State Street Navigator Securities Lending Government Money Market Portfolio | 0 | 0.00 shares | 0.00 | Short-term investment vehicle | Long | USA |